Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
50%

OVERLAP
BY WEIGHT
10

# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
36%
ALSO IN PPH
PPH
26
HOLDINGS
43%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PPH)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PPH
Overlap
ELI LILLY & CO 14.5% 17.8% 14.5%
NOVARTIS AG-ADR 6.8% 7.7% 6.8%
ABBVIE INC 9.6% 5.2% 5.2%
ASTRAZENECA PLC-SPONS ADR 5.2% 4.9% 4.9%
JOHNSON & JOHNSON 4.9% 11.6% 4.9%
MEDX Overweight Relative to PPH
ALNYLAM PHARMACEUTICALS INC 6.6%
IONIS PHARMACEUTICALS, INC. 4.5%
ABBVIE INC 4.4%
AMGEN INC 3.7%
ALKERMES PLC 3.6%
CRISPR THERAPEUTICS AG 3.4%
BIOGEN IDEC INC 2.6%
REGENERON PHARMACEUTICALS 2.3%
GALECTIN THERAPEUTICS INC 1.7%
BEAM THERAPEUTICS, INC. 1.1%
MEDX Underweight Relative to PPH
JOHNSON & JOHNSON -6.7%
NOVO-NORDISK A/S-SPONS ADR -5.9%
MCKESSON CORP -4.5%
SANOFI-AVENTIS-ADR -4.3%
ZOETIS INC -4.1%
CENCORA INC -3.9%
ELI LILLY & CO -3.3%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -2.9%
MERCK & CO. INC. -2.9%
TEVA PHARMACEUTICAL-SP ADR -1.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY